ABOUT

The Course Directors of the 2021 HBV-TAG Conference invite the submission of abstracts regarding therapeutic agents for the Hepatitis B Virus. Our goal is to provide a comprehensive update on the status of research and to stimulate collaborations, the recruitment of subjects, and ideas for the development of other studies. Authors may submit abstracts of completed work, work in progress, or work presented elsewhere within the past 12 months. All abstract submissions will be peer-reviewed and selected prior to being posting on the HBV-TAG website.

​

ABSTRACT SUBMISSION INSTRUCTIONS

The deadline for receipt of abstracts is Tuesday, June 1, 2021. All submitting authors will receive confirmation of their abstract submission via email.

ABSTRACT FORMATTING INSTRUCTIONS

• Abstracts must be submitted in PDF format. Limit abstracts to one page, typed in 12-point Times New Roman font, single-spaced with one-inch margins, and left-justified. 
   

• Organize the abstract into background/aim, methods, results, and conclusions. You must define all abbreviations. You will need to include the abstract category, abstract title, full names and institutional affiliations of all authors, and the email address of the corresponding author at the top of the abstract. 
   

• Underline the name of the presenting author. Abstracts must not contain copyrighted material unless permission has been obtained by the author. Indicate at the bottom of the page if the abstract has been presented elsewhere and at what meeting. 
   

• Submitted abstracts not meeting the above specifications will be returned.

Any questions regarding abstract submission should be directed to HBV-TAGinfo@focusmeded.com